These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14114944)

  • 1. COMPLEMENT-FIXING ANTIBODY RESPONSE AFTER ADMINISTRATION OF INACTIVATED AND ORAL POLIOVIRUS VACCINES.
    ZAVADOVA H; ZACEK K; VONKA V
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():487-94. PubMed ID: 14114944
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON HETEROLOGOUS ANTIBODY FORMATION AFTER ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Z Immunitats Allergieforsch; 1964 Jul; 127():64-74. PubMed ID: 14259857
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTIBODY RESPONSE TO TYPE 1 ORAL POLIO VACCINE.
    PETERSEN I; VONMAGNUS H
    Acta Pathol Microbiol Scand; 1964; 62():331-9. PubMed ID: 14227876
    [No Abstract]   [Full Text] [Related]  

  • 4. A COMPARISON OF THE REACTIVITY OF POLIOVIRUS COMPLEMENT-FIXING ANTIGENS (NATIVE, HEATED AND SUCROSE DENSITY GRADIENT C AND D) WITH HUMAN SERA.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL; HAGENS SJ; DUKELLIS EJ
    J Immunol; 1964 Feb; 92():261-74. PubMed ID: 14160447
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent administration of live adenovirus, type 4 and live Poliovirus, type 1 vaccines.
    Chin J; Lennette EH; Schieble JH; Magoffin RL
    Am J Epidemiol; 1968 May; 87(3):633-42. PubMed ID: 5654951
    [No Abstract]   [Full Text] [Related]  

  • 6. CYTOLOGY OF THE URINE IN CHILDREN AFTER ORAL POLIOVIRUS VACCINE.
    HART AF; CHERRY JD
    N Engl J Med; 1965 Jan; 272():174-9. PubMed ID: 14222016
    [No Abstract]   [Full Text] [Related]  

  • 7. [FIELD TRIAL WITH LIVE ORAL POLIOVIRUS VACCINE. II. PRODUCTION OF NEUTRALIZING ANTIBODIES FOLLOWING THE ADMINISTRATION OF MONOVALENT ORAL POLIOVIRUS VACCINE].
    OGAWA M; KANNO T; URASAWA S
    Sapporo Igaku Zasshi; 1963 Mar; 23():202-9. PubMed ID: 14057343
    [No Abstract]   [Full Text] [Related]  

  • 8. TRANSMISSION OF POLIO VIRUS VACCINE BY CONTAMINATED BARIUM ENEMA WITH RESULTANT ANTIBODY RISE.
    MEYERS PH; RICHARDS M
    Am J Roentgenol Radium Ther Nucl Med; 1964 Apr; 91():864-5. PubMed ID: 14139914
    [No Abstract]   [Full Text] [Related]  

  • 9. [SEROLOGICAL SURVEY OF CHILDREN FOR ANTIBODIES TO POLIOMYELITIS VIRUSES IN MOSCOW IN 1962].
    VOROSHILOVA MK; TARANOVA GP; EMELIANENKOVA VP; SHCHEGLOVA AP; KAPLAN SB
    Vopr Virusol; 1963; 29():404-9. PubMed ID: 14071275
    [No Abstract]   [Full Text] [Related]  

  • 10. STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).
    VONKA V; TARABCAK M; JANDA Z
    Arch Gesamte Virusforsch; 1964; 14():169-76. PubMed ID: 14141577
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type I vaccine at birth.
    SABIN AB; MICHAELS RH; ZIRING P; KRUGMAN S; WARREN J
    Pediatrics; 1963 Apr; 31():641-50. PubMed ID: 13975877
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE VIABILITY AND RESISTANCE OF VACCINAL STRAINS OF POLIOVIRUSES IN THE EXTERNAL ENVIRONMENT].
    BYCHKOVSKAIA OV; BABINA NS; IVANOVA OD; KISELEVA LF
    Gig Sanit; 1964 Aug; 29():45-9. PubMed ID: 14249261
    [No Abstract]   [Full Text] [Related]  

  • 13. SEROLOGICAL SURVEY OF CHILDREN IN MOSCOW FOR ANTIBODY TO POLIOVIRUSES, 1961 AND 1962.
    VOROSILOVA MK; TARANOVA GP; EMELJANENKOVA VP; SCEGLOVA AP
    Bull World Health Organ; 1965; 32(3):317-29. PubMed ID: 14315707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANTIGENIC DIFFERENTIATION OF POLIOVIRUSES BY ABSORBED HYPERIMMUNE SERA. I. ANTIGENIC DIFFERENTIATION OF TYPE I STRAINS OF DIVERSE ORIGIN.
    EYLAN E; FOGEL A; DUKLER R; RANNON L
    J Immunol; 1965 Jul; 95():171-80. PubMed ID: 14328695
    [No Abstract]   [Full Text] [Related]  

  • 15. Poliovirus antibody status and the response to trivalent oral poliovirus vaccine in Norwegian school children.
    Orstavik I; Flugsrud LB; Lahelle O
    Acta Paediatr Scand; 1968 Sep; 57(5):405-8. PubMed ID: 4974044
    [No Abstract]   [Full Text] [Related]  

  • 16. RESULTS OF INVESTIGATION OF TYPE 1 VIRUSES ISOLATED FROM PARALYTIC PATIENTS IN THE PERIOD FOLLOWING MASS VACCINATION WITH SABIN'S VACCINE IN CZECHOSLOVAKIA IN 1960.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():58-76. PubMed ID: 14128980
    [No Abstract]   [Full Text] [Related]  

  • 17. [PECULIARITIES IN VIRUS EXCRETION AND ANTIBODY FORMATION AFTER ADMINISTRATION OF A "BALANCED" LIVE VACCINE MIXTURE OF POLIOVIRUS TYPES I AND II].
    HENIGST W; MUELLER F; WUERSCHING F
    Z Hyg Infektionskr; 1963 Dec; 149():383-400. PubMed ID: 14123271
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
    Böttiger M
    Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
    [No Abstract]   [Full Text] [Related]  

  • 19. POLIOMYELITIS IN DUNDEE, 1962.
    WEIR IB; JAMIESON WM; GREEN DM
    Br Med J; 1964 Oct; 2(5413):853-7. PubMed ID: 14185637
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE ANTIBODY RESPONSE TO ANTIPOLIOMYELITIC VACCINE (SABIN TYPE) IN A GROUP OF CHILDREN OF THE PROVINCE OF PISA].
    SANTOPADRE G; RUSCHI A; BENDINELLI M; ROOK GA
    Riv Ital Ig; 1964; 24():571-82. PubMed ID: 14337303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.